Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyzing Short Interest and Market Sentiment Towards Lucid Group Inc NYSELCID

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Finance_ Chart Down
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Lucid Group Inc. (NYSE:LCID) has seen a 6.57% decrease in its short percent of float since the last report on March 8, 2024, with 254.07 million shares sold short, representing 21.6% of available regular shares for trading. Traders would take an average of 8.62 days to cover their short positions based on trading volume.

Understanding short interest is essential as it reflects market sentiment towards a stock; an increase can indicate bearishness, while a decrease may signal bullishness. Comparing peers is a common method to evaluate company performance based on industry, size, and financial structure similarities.

Institutional investors shorting Lucid Group include GTS Securities LLC, Barclays PLC, and others. As of January 31st, Lucid Group had 269.74 million shares sold short, accounting for 30.85% of its floating shares. The company’s short interest increased in January, suggesting negative investor sentiment.

Institutional owners such as Public Investment Fund and Vanguard Group Inc. hold a significant number of shares in Lucid Group. The share price decline from $12.07 to $3.42 over a year indicates a 71.67% decrease.

Regular updates on short interest data provide valuable insights into market sentiment and investor behavior towards Lucid Group.

LCID Stock Price Analysis and Forecast for March 8, 2024

On March 8, 2024, LCID stock had a relatively uneventful day in terms of price movement. The stock opened at $3.15, which was $0.03 higher than its previous close. Throughout the trading day, the price of LCID shares remained flat, with no significant changes in value. This resulted in a 0.00% change in the stock price by the time the market closed.

Investors may be keeping a close eye on LCID to see if it can break out of its current trading range and potentially reverse its downward trend. Any positive news or developments related to the company could potentially spark a rally in the stock price.

LCID Stock Performance Analysis: Flat Revenue, Decrease in Net Income, Slight Increase in EPS – March 8, 2024

On March 8, 2024, LCID stock had a mixed performance based on the financial data provided by CNN Money. The total revenue for the company was reported at $595.27 million for the past year, which remained flat compared to the previous year. Similarly, the total revenue for the fourth quarter of the year was $157.15 million, also remaining flat compared to the previous quarter.

The net income for LCID showed a significant decrease when comparing the past year to the current year. The net income for the past year was reported at -$2.83 billion, which was a decrease of 116.83% compared to the previous year. On the other hand, the net income for the fourth quarter of the year was -$653.77 million, showing no change compared to the previous quarter.

Despite the decrease in net income, the earnings per share (EPS) for LCID showed a slight increase when comparing the past year to the current year. The EPS for the past year was reported at -$1.36, which was an increase of 10.09% compared to the previous year. The EPS for the fourth quarter of the year was -$0.29, showing no change compared to the previous quarter.

Overall, the financial performance of LCID stock on March 8, 2024, was mixed with flat total revenue, a significant decrease in net income, and a slight increase in earnings per share. Investors and analysts may need to further analyze the company’s financial health and future prospects to make informed investment decisions.

Tags: LCID
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Real Estate Investment Trading online

Title Strengthening Financial Position Four Real Estate Investment Trusts REITs That Recently Boosted Dividends

Businesses finance

Chardan Capital Reaffirms Buy Rating for Dyne Therapeutics with Price Target Increase

Cryptocurrency Markets and money

Analyst Josh Siegler Bullish on Bitfarms with Increased Price Target

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com